Second Amendment to Amended and Restated Executive Employment Agreement, effective as of April 11, 2024, by and between the Registrant and Troy E. Wilson, Ph.D., J.D
Exhibit 10.1
Kura Oncology, Inc.
Second Amendment to
Amended and Restated Executive Employment Agreement
This Second Amendment to Amended and Restated Executive Employment Agreement (this “Amendment”), amending that certain Amended and Restated Executive Employment Agreement effective as of January 29, 2016, as amended by that certain Amendment to Amended and Restated Executive Employment Agreement effective as of February 19, 2021 (collectively, the “Employment Agreement”) by and between Kura Oncology, Inc. (the “Company”) and Troy
E. Wilson, Ph.D., J.D. (the “Executive”), is entered into effective as of April 11, 2024.
RECITALS
Whereas, the Company and the Executive have previously entered into the Employment Agreement; and
Whereas, the Company and the Executive desire to amend the Employment Agreement as set forth herein.
AGREEMENT
Now, Therefore, in consideration of the foregoing and the promises and covenants contained herein and in the Employment Agreement, and for other good and valuable consideration, the receipt of which is hereby acknowledged, the parties hereto agree as follows:
1
[Remainder of Page Intentionally Left Blank]
2
In Witness Whereof, the parties have executed this Second Amendment to Amended and Restated Executive Employment Agreement as of the date first written above.
COMPANY:
Kura Oncology, Inc. | ||
|
|
|
By: | /s/ Kathy Ford | |
Name: | Kathy Ford | |
Title: | COO | |
|
| |
EXECUTIVE: | ||
|
| |
/s/ Troy Wilson, Ph.D., J.D. | ||
Troy Wilson, Ph.D., J.D. |